Pacira BioSciences, Inc. PCRX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.92M+78.1% | $1.64M-69.9% | $5.43M+212% | -$4.85M-201% | $4.81M— | ||
| $21.33M-0.1% | $21.34M+0.7% | $21.19M-22.4% | $27.32M+29.1% | $21.17M-0.4% | ||
| $13.54M+0.3% | $13.5M-3.4% | $13.98M-9.7% | $15.47M+6.3% | $14.55M+18.6% | ||
| $25.68M-41.2% | $43.69M-28.2% | $60.83M+406% | $12.01M-66.1% | $35.46M+7.0% | ||
| $2.72M+1,150% | $218K-94.4% | $3.87M+43.5% | $2.7M-68.4% | $8.55M+304% | ||
| $335K— | —— | —— | —— | $16.7M— | ||
| $19.44M+0.6% | $19.33M-55.7% | $43.61M-29.8% | $62.16M+343% | -$25.63M-6,864% | ||
| $50.05M+3.7% | $48.25M-3.6% | $50.04M0.0% | $50.04M— | $0-100% | ||
| $5M0.0% | $5M— | —— | —— | $0— | ||
| -$59.4M-15.0% | -$51.65M+79.9% | -$257.48M-348% | -$57.51M-1,821% | -$2.99M— | ||
| -$14.24M— | $0+100% | -$152.9M-1,006% | $16.87M+147% | $6.84M-77.8% | ||
| $22.96M-47.2% | $43.47M-23.7% | $56.96M+512% | $9.32M-65.4% | $26.91M-13.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pacira BioSciences, Inc. generate?
- Pacira BioSciences, Inc. (PCRX) generated $142.2M in operating cash flow over the trailing twelve months.
- What is Pacira BioSciences, Inc.'s free cash flow?
- After $9.5M of capital expenditures, Pacira BioSciences, Inc.'s free cash flow was $132.7M over the trailing twelve months, down 16.8% year over year.
- Where does Pacira BioSciences, Inc.'s cash flow data come from?
- Every line is extracted from Pacira BioSciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
